Next Article in Journal
Comparison of Post-Vaccination Response between mRNA and Vector Vaccines against SARS-CoV-2 in Terms of Humoral Response after Six Months of Observation
Next Article in Special Issue
Safety, Tolerability, and Immunogenicity of Booster Dose with MVC-COV1901 or MVC-COV1901-Beta SARS-CoV-2 Vaccine in Adults: A Phase I, Prospective, Randomized, Open-Labeled Study
Previous Article in Journal
Association between Religious Beliefs and HPV Vaccination Attitudes among College Students
Previous Article in Special Issue
Effectiveness of the Booster Dose in Protecting against COVID-19, Colombia 2022
 
 
Brief Report

Article Versions Notes

Vaccines 2023, 11(10), 1624; https://doi.org/10.3390/vaccines11101624
Action Date Notes Link
article pdf uploaded. 22 October 2023 11:38 CEST Version of Record https://www.mdpi.com/2076-393X/11/10/1624/pdf-vor
article supplementary file uploaded. 22 October 2023 11:38 CEST - https://www.mdpi.com/2076-393X/11/10/1624#supplementary
article xml file uploaded 23 October 2023 08:22 CEST Original file -
article xml uploaded. 23 October 2023 08:22 CEST Update -
article pdf uploaded. 23 October 2023 08:22 CEST Updated version of record https://www.mdpi.com/2076-393X/11/10/1624/pdf-vor
article html file updated 23 October 2023 08:23 CEST Original file -
article xml file uploaded 24 October 2023 10:19 CEST Update -
article xml uploaded. 24 October 2023 10:19 CEST Update https://www.mdpi.com/2076-393X/11/10/1624/xml
article pdf uploaded. 24 October 2023 10:20 CEST Updated version of record https://www.mdpi.com/2076-393X/11/10/1624/pdf
article html file updated 24 October 2023 10:21 CEST Update https://www.mdpi.com/2076-393X/11/10/1624/html
Back to TopTop